Product Program year 2020 Source: CMS Open Payments

(815) Thiola

Drug Kidney Stones

NDC 00178-0900-0

Open in the dashboard

General payments

$331,514

5,381 payments

Research payments

$214,313

1 payment

Through program year 2020, $331,514 in general payments and $214,313 in research payments were reported against (815) Thiola (Kidney Stones).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2020 General $80,298 2,275
2020 Research $214,313 1
2019 General $251,216 3,106

Breakdown

Who paid General payments · program years 2019–2020
  1. Retrophin, Inc. $331,514 5,381 payments
Top recipients General payments · program year 2020
  1. Robert Nadler Urology · Springfield, IL $15,952 20% · 14 payments
  2. Derek Larson Nephrology · Creve Coeur, MO $6,807 8% · 13 payments
  3. Anis Rauf Nephrology · Hinsdale, IL $5,650 7% · 12 payments
  4. Glenn Preminger Urology · Durham, NC $5,357 7% · 13 payments
  5. Roger Sur Urology · San Diego, CA $4,404 5% · 10 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Urology $55,057 70% · 788 practitioners
  2. Nephrology Internal Medicine $19,406 25% · 272 practitioners
  3. Pediatric Gastroenterology Pediatrics $1,043 1% · 9 practitioners
  4. Internal Medicine $740 <1% · 17 practitioners
  5. Pediatric Nephrology Pediatrics $339 <1% · 20 practitioners

The top 5 of 33 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Illinois $25,522 32% · 90 recipients
  2. Missouri $8,513 11% · 50 recipients
  3. North Carolina $7,607 9% · 19 recipients
  4. California $5,988 7% · 66 recipients
  5. Texas $4,950 6% · 72 recipients

The top 5 of 48 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

5,381 general · 1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record